Orange Book product · Generic (ANDA)
BRIMONIDINE TARTRATE
BRIMONIDINE TARTRATE
At a glance
Aug 01, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 01, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
BRIMONIDINE TARTRATE
Strength
0.1%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AB
Application
ANDA 216909
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BRIMONIDINE TARTRATE
- 2024LUMIFY PRESERVATIVE FREEBrand (NDA)
NDA 218424 · BAUSCH AND LOMB INC
- 2017LUMIFYBrand (NDA)
NDA 208144 · BAUSCH AND LOMB INC
- 2013MIRVASOBrand (NDA)
NDA 204708 · GALDERMA LABS LP
- 2006QOLIANABrand (NDA)
NDA 021764 · SANDOZ
- 2005ALPHAGAN PBrand (NDA)
NDA 021770 · ABBVIE
- 2001ALPHAGAN PBrand (NDA)
NDA 021262 · ABBVIE
- 1997ALPHAGANBrand (NDA)
NDA 020490 · ALLERGAN
- 1996ALPHAGANBrand (NDA)
NDA 020613 · ALLERGAN
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 218558 · MICRO LABS
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 220398 · MANKIND PHARMA
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 219219 · GLAND
- 2025BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 217599 · UPSHER SMITH LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
